APOGEE THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 49.21 USD | -6.12% |
|
-8.87% | +76.13% |
Chart calendar Apogee Therapeutics, Inc.
e2246740bb04f737f538239dda337a9.3gKdmx_kjyl-z2KCs61J_LU6dkhdQln9sv1qOsfRigo.hmer4VqQ30YH_Ajw4ZsgrZgMGxIpdQytxZspXaW72X-GVfL3W7fqfgn_Ug~ec2f770e70d6d8032d987bd74c71cc0d
Upcoming events on Apogee Therapeutics, Inc.
Past events on Apogee Therapeutics, Inc.
| 2024-05-15 06:40 pm | BofA Securities Health Care Conference |
| 2024-05-13 07:00 am | Q1 2024 Earnings Release |
| 2024-03-05 07:00 am | APG777 Phase 1 Trial Interim Results Call |
| 2024-03-05 06:10 am | Q4 2023 Earnings Release |
| 2024-01-09 10:30 am | JPMorgan Healthcare Conference |
| 2023-11-28 11:15 am | Evercore ISI HealthCONx Conference |
| 2023-11-15 09:30 am | Jefferies London Healthcare Conference |
| 2023-11-14 10:20 am | Stifel Healthcare Conference |
| 2023-11-13 07:30 am | Q3 2023 Earnings Release |
| 2023-11-06 02:30 pm | Guggenheim Securities Inflammation & Immunology Conference |
| 2023-10-10 | European Academy of Dermatology and Venereology Conference |
| 2023-09-20 09:30 am | Stifel Immunology & Inflammation Virtual Summit |
| 2023-08-28 07:30 am | Q2 2023 Earnings Release |
| 2023-08-13 | Stifel Biotech Summer Summit |
| 2023-08-07 | Wedbush PacGrow Healthcare Conference |
Annual results
| Fiscal Period | December | 2023 | 2024 |
|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 0,00 - | 61,0 |
|
EBIT Million USD | Released Forecast Spread | -93,0 -79,1 -17.51% | -163 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -84,0 -80,3 -4.63% | -154 |
|
Net income Million USD | Released Forecast Spread | -84,0 -77,3 -8.67% | -150 |
|
EPS USD | Released Forecast Spread | -3,36 -2,83 -18.8% | -2,70 |
| Announcement Date | 05/03/24 | - |
Quarterly results
| Fiscal Period | December | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | |
|
EBITDA Million USD | Released Forecast Spread | -38,2 6,00 -735.87% | 12,0 | 18,0 | 25,0 | ||||||
|
EBIT Million USD | Released Forecast Spread | -18,9 -14,4 -30.99% | -24,3 -18,1 -34.63% | -37,2 -26,8 -38.54% | -38,2 -30,1 -26.91% | -39,6 | -41,6 | -44,7 | -43,2 | -45,1 | |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -18,9 -14,7 -28.56% | -20,8 -18,3 -13.63% | -31,7 -28,0 -13.2% | -32,1 -29,9 -7.3% | -36,1 | -40,0 | -46,0 | -45,0 | -48,0 | |
|
Net income Million USD | Released Forecast Spread | -12,5 | -18,9 -14,7 -28.56% | -20,8 -18,3 -13.63% | -31,7 -27,1 -16.92% | -32,1 -28,9 -10.9% | -35,2 | -38,6 | -43,8 | -39,7 | -41,5 |
|
EPS USD | Released Forecast Spread | -2,51 | -3,78 -1,70 -122.09% | -0,51 -0,41 -25% | -0,32 -0,66 51.15% | -0,64 -0,57 -12.68% | -0,63 | -0,67 | -0,77 | -0,67 | -0,70 |
| Announcement Date | 22/06/23 | 28/08/23 | 13/11/23 | 05/03/24 | 13/05/24 | - | - | - | - | - |
| 2024-06-30 | IMMUNOVANT, INC.: Q4 2024 Earnings Release (Projected) |
| 2024-07-15 01:45 am | ADDLIFE AB: Q2 2024 Earnings Release |
| 2024-07-21 | MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release (Projected) |
| 2024-07-23 | SYNGENE INTERNATIONAL LIMITED: Q1 2025 Earnings Release (Projected) |
| 2024-07-23 | ALKERMES PLC: Q2 2024 Earnings Release (Projected) |
| 2024-07-23 | IQVIA HOLDINGS INC.: Q2 2024 Earnings Release (Projected) |
| 2024-07-23 | ICON PUBLIC LIMITED COMPANY: Q2 2024 Earnings Release (Projected) |
| 2024-07-24 | LONZA GROUP AG: Q2 2024 Earnings Release |
| 2024-07-25 01:00 am | BACHEM HOLDING AG: Q2 2024 Earnings Release |
| 2024-07-25 | PHARVARIS N.V.: Q2 2024 Earnings Release (Projected) |
Past sector events for Apogee Therapeutics, Inc.
| Today | CUREVAC N.V.: Q1 2024 Earnings Release (Projected) |
| Today | EVOTEC SE: Q1 2024 Earnings Release |
| 2024-05-21 07:00 am | EXSCIENTIA PLC: Q1 2024 Earnings Release |
| 2024-05-20 | ALVOTECH: Q1 2024 Earnings Release |
| 2024-05-17 02:00 am | BIOARCTIC AB: Q1 2024 Earnings Release |
| 2024-05-15 04:05 pm | CULLINAN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-14 | GNI GROUP LTD.: Q1 2024 Earnings Release |
| 2024-05-14 04:05 pm | NUVATION BIO INC.: Q1 2024 Earnings Release |
| 2024-05-14 07:30 am | ABSCI CORPORATION: Q1 2024 Earnings Release |
| 2024-05-14 01:50 am | BELITE BIO, INC: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- APGE Stock
- Calendar Apogee Therapeutics, Inc.